Hours of testimony in Philadelphia federal court on Ozempic and other GLP-1 drugs could significantly impact ongoing lawsuits against manufacturers, as detailed in the Pittsburgh Post-Gazette.
—-
Author : Charlotte Adams
Publish date : 2025-05-19 00:30:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8

Lengthy Testimonies in Philadelphia Court Could Transform Lawsuit Against Ozempic and Other GLP-1 Drugmakers
Leave a Comment Leave a Comment